Equities.com created the Small-Cap Stars, our proprietary list of small-cap companies best-positioned for future success, to help investors identify those small-cap companies with the most fundamental strength and the best chance for future success.
In 2013, the Small-Cap Stars generated returns in excess of 45%, and 2014 brings 369 new companies that feature an excellent chance at breaking through.
Here are the today's top-performing Small-Cap Stars as of noon on the east coast:
Provectus Biopharmaceuticals Inc. (PVCT)
Provectus Biopharmaceuticals Inc. gained 13.1% to $0.95 in morning trading today. Volume reached 2,563,380 by noon. The stock's average daily volume is 383,749 shares. Provectus Biopharmaceuticals Inc. has a 52-week high of $6.03 and a 52-week low of $0.30, and its 50-day SMA and 200-day SMA are $0.95 and $1.65 respectively.
Provectus Biopharmaceuticals Inc is a development-stage pharmaceutical company. It develops, licenses, and sells pharmaceutical products for oncology and dermatology indications.
Lrad Corporation (LRAD)
Lrad Corporation gained 11.44% to $3.02 in morning trading today. Volume reached 525,256 by noon. The stock's average daily volume is 176,479 shares. Lrad Corporation has a 52-week high of $2.95 and a 52-week low of $1.26, its P/E ratio is 16.4, and its 50-day SMA and 200-day SMA are $2.06 and $1.96 respectively.
LRAD Corp is engaged in the design, development and commercialization of directed sound technologies and products.
Net Element Inc. (NETE)
Net Element Inc. gained 9.26% to $1.77 in morning trading today. Volume reached 15,507 by noon. The stock's average daily volume is 269,010 shares. Net Element Inc. has a 52-week high of $5.90 and a 52-week low of $0.88, and its 50-day SMA and 200-day SMA are $1.87 and $2.88 respectively.
Net Element Inc is a financial technology-driven group specializing in mobile payments and value-added transactional services in emerging countries and in the United States.
Insys Therapeutics Inc (INSY)
Insys Therapeutics Inc gained 6.61% to $37.05 in morning trading today. Volume reached 382,207 by noon. The stock's average daily volume is 595,063 shares. Insys Therapeutics Inc has a 52-week high of $57.91 and a 52-week low of $16.20, its P/E ratio is 22.8, and its 50-day SMA and 200-day SMA are $28.26 and $32.99 respectively.
Insys Therapeutics, Inc is a commercial-stage specialty pharmaceutical company. It develops and commercializes supportive care products that target the unmet needs of cancer patients, with an initial focus on cancer supportive care.
Arrowhead Research Corp (ARWR)
Arrowhead Research Corp gained 6.02% to $14.78 in morning trading today. Volume reached 2,312,320 by noon. The stock's average daily volume is 2,740,545 shares. Arrowhead Research Corp has a 52-week high of $27.63 and a 52-week low of $3.79, and its 50-day SMA and 200-day SMA are $12.92 and $13.28 respectively.
Arrowhead Research Corp is a biopharmaceutical company developing targeted RNAi therapeutics.
Equities.com's Small-Cap Stars: Taking Your Portfolio to the Moon
The equities.com Small-Cap Stars represent a list of small caps that our system has selected as among those most likely to make big gains this year. Our systems takes hundreds of small-cap companies and runs a complex statistical regression to determine how the best companies differ from the worst based on a few dozen fundamental metrics. This allows us to identify an industry-specific statistical profile that previously successful companies featured immediately prior to their stock taking off. Then, by applying that profile to the current markets, we can find those companies in the best position for big potential gains in the coming year.
These 369 small caps should give any investor more than a few investment ideas to get started with, and ones that should have a real chance to succeed in the volatile and unpredictable small-cap investing space.
All data provided by QuoteMedia and was accurate as of 12:00 pm ET.